Join us on Wednesday, March 19 at 10 a.m. CST for the next installment of ASGCT's Molecular Therapy Presents webinar series: Immunotherapy in Autoimmune Disease. This event is FREE for ASGCT members.
With seven CAR T cell therapies currently approved in the United States to treat certain forms of cancer, researchers and clinicians are exploring other applications to treat autoimmune diseases. Following the ground-breaking first report of a patient with severe systemic lupus erythematosus who was successfully treated with CD19 CAR T cells, clinical trials of CAR T cell therapies for lupus nephritis, scleroderma, myositis, and multiple sclerosis have taken flight across the world.
Moderator
Boris Fehse, PhD
University Medical Centre Hamburg-Eppendorf
Speakers
Lili Wang, PhD
University of California Los Angeles
Lena Kristina Pfeffer, MD
University Medical Center Hamburg-Eppendorf
Fabian Müller, MD
University Hospital Erlangen
Learning Objectives
After attending this webinar, participants will be able to describe the emerging applications of CAR T cell therapy in autoimmune diseases and discuss ongoing clinical trials exploring its potential in conditions such as lupus nephritis, scleroderma, myositis, and multiple sclerosis.